Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tetra Bio-Pharma (OP:TBPMF)

N/A UNCHANGED
Last Price Updated: 1:28 PM EDT, Sep 15, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tetra Bio-Pharma

< Previous 1 2 3 4 Next >
Cannabis Stock Gainers And Losers From May 12, 2021
GAINERS: Canada House Wellness (OTC... 
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From May 11, 2021
GAINERS: Claritas Pharmaceuticals (... 
Via Benzinga
Topics Cannabis
Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain
First ever clinical trial using pharmaceutical grade cannabis medication for use in managing uncontrolled cancer pain due to advanced cancer QIXLEEF™ has the potential to transform the pain market... 
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Cannabis Stock Gainers And Losers From May 7, 2021
GAINERS: Tetra Bio Pharma (OTC: 
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From May 6, 2021
GAINERS: Rhinomed (OTC: 
Via Benzinga
Topics Cannabis
Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial
First ever Phase 2 clinical trial designed to evaluate the effect of cannabis against an opioid treatment QIXLEEF™ has the potential to transform the pain market OTTAWA, ON / ACCESSWIRE / May 6, 2021 /... 
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
The Cannabis-Centric BioPharma Stocks Index Declined In April But Remains Up YTD
13 cannabis-centric clinical-stage biopharmaceutical companies and their major operational activities in April to assist those considering investing in this marijuana sub-category, 
Via Talk Markets
Topics Cannabis
Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios
This Definitive Agreement is expected to generate an excess of $47,5M CAD in revenue for Tetra OTTAWA, ON / ACCESSWIRE / May 5, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company")... 
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals
A first of its kind synthetic cannabinoid medication to manage eye pain in the veterinary setting OTTAWA, ON / ACCESSWIRE / May 4, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)... 
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Cannabis Stock Gainers And Losers From May 3, 2021
GAINERS: Rhinomed (OTC: 
Via Benzinga
Topics Cannabis
Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada
The addressable market in Canada is estimated to be $80M CDN by 2022. Tetra also applies for a Health Canada Cannabis Drug License OTTAWA, ON / ACCESSWIRE / May 3, 2021 / Tetra Bio-Pharma Inc. ("Tetra"... 
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Cannabis Stock Gainers And Losers From April 30, 2021
GAINERS: Rhinomed (OTC: 
Via Benzinga
Topics Cannabis
Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority
Tetra plans for global commercialization of QIXLEEF OTTAWA, ON / ACCESSWIRE / April 28, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a leader in... 
From Tetra Bio-Pharma
Via AccessWire
Topics Intellectual Property
Cannabis Stock Gainers And Losers From April 26, 2021
GAINERS: CLS Holdings USA (OTC: 
Via Benzinga
Topics Cannabis
Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week
Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC. 
Via Talk Markets
Cannabis Stock Gainers And Losers From April 23, 2021
GAINERS: Tetra Bio Pharma (OTC: 
Via Benzinga
Topics Cannabis
Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial
- First clinical study to assess cannabis as an alternative to morphine - Tetra completes manufacturing of QIXLEEF clinical trial drug for REBORN1 trial - Export permit received from Health Canada for... 
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Cannabis Stock Gainers And Losers From April 22, 2021
GAINERS: Rhinomed (OTC: 
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From April 21, 2021
GAINERS: Wize Pharma (OTC: 
Via Benzinga
Topics Cannabis
Tetra Bio-Pharma Announces Granting of U.S. Patent for Treatment of Interstitial Cystitis
- Tetra strengthens its intellectual property portfolio - Approximately 12% of women may have early symptoms of Interstitial Cystitis OTTAWA, ON / ACCESSWIRE / April 15, 2021 / Tetra Bio-Pharma Inc.... 
From Tetra Bio-Pharma
Via AccessWire
Topics Intellectual Property
Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada
- REDUVO would have Canada's only Drug Identification Number for a THC-based prescription drug - The addressable market is estimated to be $80M CDN by 2022 OTTAWA, ON / ACCESSWIRE / April 14, 2021 /... 
From Tetra Bio-Pharma
Via AccessWire
Topics Intellectual Property
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.